In contrast to the antibiotic activity of doxycycline, it inhibits the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and regulates genes that regulate cell proliferation by interacting with cell surface integrin αvβ3 in ER-negative breast cancer cells. This evidence concerns the gene MAPK3 and breast carcinoma.